4.5 Review

Evasion of Early Antiviral Responses by Herpes Simplex Viruses

期刊

MEDIATORS OF INFLAMMATION
卷 2015, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2015/593757

关键词

-

资金

  1. FONDECYT [1140011, 110, 1140010, 11075060, 1100926, 1110518, 1110397]
  2. Millennium Institute on Immunology and Immunotherapy [P09/016-F]
  3. [CRP-1CGLB CRP/CHI14-01]
  4. [COPEC-UC J-139]

向作者/读者索取更多资源

Besides overcoming physical constraints, such as extreme temperatures, reduced humidity, elevated pressure, and natural predators, human pathogens further need to overcome an arsenal of antimicrobial components evolved by the host to limit infection, replication and optimally, reinfection. Herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2) infect humans at a high frequency and persist within the host for life by establishing latency in neurons. To gain access to these cells, herpes simplex viruses (HSVs) must replicate and block immediate host antiviral responses elicited by epithelial cells and innate immune components early after infection. During these processes, infected and noninfected neighboring cells, as well as tissue-resident and patrolling immune cells, will sense viral components and cell-associated danger signals and secrete soluble mediators. While type-I interferons aim at limiting virus spread, cytokines and chemokines will modulate resident and incoming immune cells. In this paper, we discuss recent findings relative to the early steps taking place during HSV infection and replication. Further, we discuss how HSVs evade detection by host cells and the molecular mechanisms evolved by these viruses to circumvent early antiviral mechanisms, ultimately leading to neuron infection and the establishment of latency.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Susan M. Bueno, Katia Abarca, Pablo A. Gonzalez, Nicolas M. S. Galvez, Jorge A. Soto, Luisa F. Duarte, Barbara M. Schultz, Gaspar A. Pacheco, Liliana A. Gonzalez, Yaneisi Vazquez, Mariana Rios, Felipe Melo-Gonzalez, Daniela Rivera-Perez, Carolina Iturriaga, Marcela Urzua, Angelica Dominguez, Catalina A. Andrade, Roslye Berrios-Rojas, Gisela Canedo-Marroquin, Camila Covian, Daniela Moreno-Tapia, Farides Saavedra, Omar P. Vallejos, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela Gonzalez, Paula Guzman, Paula Munoz Venturelli, Carlos M. Perez, Marcela Potin, Alvaro Rojas, Rodrigo A. Fasce, Jorge Fernandez, Judith Mora, Eugenio Ramirez, Aracelly Gaete-Argel, Aaron Oyarzun-Arrau, Fernando Valiente-Echeverria, Ricardo Soto-Rifo, Daniela Weiskopf, Alessandro Sette, Gang Zeng, Weining Meng, Jose Gonzalez-Aramundiz, Alexis M. Kalergis

Summary: Vaccination with CoronaVac in Chilean adults aged >= 18 years is safe and induces immune responses, including antibody production and T cell activation. The vaccine demonstrates the generation of neutralizing antibodies and T cell responses in both the 18-59 and >= 60 age groups.

CLINICAL INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Bioinformatic and experimental characterization of SEN1998: a conserved gene carried by the Enterobacteriaceae-associated ROD21-like family of genomic islands

Alejandro Pina-Iturbe, Guillermo Hoppe-Elsholz, Paulina A. Fernandez, Carlos A. Santiviago, Pablo A. Gonzalez, Susan M. Bueno

Summary: This study aims to gain a better understanding of the factors involved in the excision of genomic islands. By studying the pathogenicity island ROD21 in Salmonella, a conserved gene SEN1998 related to excision was identified, providing insights into the mechanism of ROD21 excision.

SCIENTIFIC REPORTS (2022)

Review Immunology

Aging envisage imbalance of the periodontium: A keystone in oral disease and systemic health

Veronica Villalobos, Mauricio Garrido, Antonia Reyes, Christian Fernandez, Catalina Diaz, Vicente A. Torres, Pablo A. Gonzalez, Monica Caceres

Summary: Aging negatively affects gingival wound healing and alters cellular responses and tissue functions. Salivary antimicrobial peptides and pathogenic infections (such as P. gingivalis and HSV) are associated with periodontal disease progression and other pathologies.

FRONTIERS IN IMMUNOLOGY (2022)

Review Microbiology

Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections

Abel A. Soto, Gerardo Ortiz, Sofia Contreras, Ricardo Soto-Rifo, Pablo A. Gonzalez

Summary: Herpesviruses are highly prevalent double-stranded DNA viruses that can cause a wide range of clinical manifestations and diseases. Chemical modifications of viral RNA and DNA play critical roles in modulating the life cycle of herpesviruses during the lytic and latent phases of infection.

MICROORGANISMS (2022)

Review Immunology

Is there a role for herpes simplex virus type 1 in multiple sclerosis?

Luisa F. Duarte, Sebastian Gatica, Almendra Castillo, Alexis M. Kalergis, Susan M. Bueno, Claudia A. Riedel, Pablo A. Gonzalez

Summary: Numerous studies have linked the onset and severity of multiple sclerosis (MS) with viral infections. Herpes simplex virus type 1 (HSV-1), which is neurotropic and commonly found in the brains of healthy individuals, has been suggested to be associated with MS. This review discusses the reported connections between HSV-1 and MS.

MICROBES AND INFECTION (2023)

Review Virology

LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections

Linmar Rodriguez-Guilarte, Mario A. Ramirez, Catalina A. Andrade, Alexis M. Kalergis

Summary: LAG-3 is an inhibitory receptor expressed on immune cells, which regulates T cell activation and effector functions in the immune response. Immunotherapies targeting immune checkpoints, including LAG-3, have shown promise in controlling malignant tumors and chronic viral diseases.

VIRUSES-BASEL (2023)

Article Microbiology

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children

Jorge A. Soto, Felipe Melo-Gonzalez, Cristian Gutierrez-Vera, Barbara M. Schultz, Roslye Berrios-Rojas, Daniela Rivera-Perez, Alejandro Pina-Iturbe, Guillermo Hoppe-Elsholz, Luisa F. Duarte, Yaneisi Vazquez, Daniela Moreno-Tapia, Mariana Rios, Pablo A. Palacios, Richard Garcia-Betancourt, Alvaro Santibanez, Gaspar A. Pacheco, Constanza Mendez, Catalina A. Andrade, Pedro H. Silva, Benjamin Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cardenas, Marcela Gonzalez, Macarena Goldsack, Valentina Gutierrez, Marcela Potin, Andrea Schilling, Lorena Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A. Fasce, Jorge Fernandez, Judith Mora, Eugenio Ramirez, Aracelly Gaete-Argel, Monica L. Acevedo, Fernando Valiente-Echeverria, Ricardo Soto-Rifo, Angello Retamal-Diaz, Nathalia Munoz-Jofre, PedCoronaVac, Xing Meng, Qianqian Xin, Eduardo Alarcon-Bustamante, Jose Gonzalez-Aramundiz, Nicole Le Corre, Maria Javiera Alvarez-Figueroa, Pablo A. Gonzalez, Katia Abarca, Cecilia Perret, Leandro J. Carreno, Susan M. Bueno, Alexis M. Kalergis

Summary: CoronaVac has been shown to be safe and immunogenic in children and adolescents in Chile, inducing neutralizing antibody secretion and activating CD4+ T cells against SARS-CoV-2 and its variants.
Review Microbiology

Interplay between lipid metabolism, lipid droplets and RNA virus replication

Monica A. Farias, Benjamin Diethelm-Varela, Alexis M. Kalergis, Pablo A. Gonzalez

Summary: Lipids play crucial roles in the cell as membrane components, signaling molecules, and energy storage sources. Lipid droplets, composed of neutral lipids such as triglycerides and cholesterol esters, are not only cellular energy reserves but also involved in regulating oxidative stress, cellular lipotoxicity, and modulating pathogen infection through immune regulation. Lipid metabolism and lipid droplets play important roles in the replication cycle of RNA viruses, and understanding these processes may reveal new targets for antiviral drugs.

CRITICAL REVIEWS IN MICROBIOLOGY (2023)

Article Hematology

Procoagulant phenotype induced by oxidized high-density lipoprotein associates with acute kidney injury and death

Yolanda Prado, Lorena Perez, Felipe Eltit, Cesar Echeverria, Felipe M. Llancalahuen, Pablo Tapia, Pablo A. Gonzalez, Alexis M. Kalergis, Claudio Cabello-Verrugio, Felipe Simon

Summary: Severe systemic inflammation can lead to oxidative stress, promoting the conversion of high-density lipoprotein (HDL) to oxidized HDL (oxHDL), which interacts with vascular endothelial cells (ECs). OxHDL can acquire procoagulant features and modulate coagulation, which has been linked with organ failure in ICU patients. However, the exact role and underlying molecular mechanism of oxHDL in generating a procoagulant phenotype and causing organ failure and death are still unknown.

THROMBOSIS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Heme Oxygenase-1 Expression in Dendritic Cells Contributes to Protective Immunity against Herpes Simplex Virus Skin Infection

Eduardo I. Tognarelli, Luisa F. Duarte, Monica A. Farias, Felipe A. Cancino, Nicolas Corrales, Francisco J. Ibanez, Claudia A. Riedel, Susan M. Bueno, Alexis M. Kalergis, Pablo A. Gonzalez

Summary: Stimulating HO-1 expression in HSV-infected dendritic cells can promote cell viability and inhibit viral egress. It also promotes the expression of anti-inflammatory molecules and activation of virus-specific CD4(+) T cells. Transferring HSV-infected dendritic cells with induced HO-1 expression can enhance virus-specific T cell activation and improve the outcome of HSV-1 skin infection.

ANTIOXIDANTS (2023)

Article Immunology

Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects

Luisa F. Duarte, Yaneisi Vazquez, Benjamin Diethelm-Varela, Valentina Pavez, Roslye Berrios-Rojas, Claudia A. Riedel, Constanza Mendez, Jessica A. White, Alexis M. Kalergis, Susan M. Bueno, Pablo A. Gonzalez

Summary: This study aimed to identify potential antigens for distinguishing humoral responses after vaccination with CoronaVac, natural infection, or breakthrough infection. The results showed that CoronaVac vaccination induced higher levels of antibodies against the viral membrane protein, while the levels of IgG antibodies against the nucleocapsid protein were similar between the booster dose group and convalescent subjects. Breakthrough case patients had the highest antibody levels against the N and M proteins.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Immunology

Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study

Sebastian Mondaca, Benjamin Walbaum, Nicole Le Corre, Marcela Ferres, Alejandro Valdes, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, Patricia Macanas-Pirard, Patricio Ross, Betzabe Cisternas, Patricia Perez, Olivia Cabrera, Valentina Cerda, Ivana Ormazabal, Aldo Barrera, Maria E. Prado, Maria I. Venegas, Silvia Palma, Richard Broekhuizen, Alexis M. Kalergis, Susan M. Bueno, Manuel A. Espinoza, M. Elvira Balcells, Bruno Nervi

Summary: Cancer patients receiving chemotherapy treatment have a lower immune response to SARS-CoV-2 vaccines. Our study demonstrated that booster vaccines elicit strong humoral and cellular responses among cancer patients receiving chemotherapy, regardless of the type of vaccine used as a priming dose. The homologous vaccine regimen was associated with higher neutralizing antibody positivity and total antibody levels.

VACCINES (2023)

Review Microbiology

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines

Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis

Summary: RSV is a significant cause of morbidity and mortality in young children and older adults. The development of RSV vaccines is guided by epidemiologic and pathophysiological evidence, using various vaccine technologies. Currently, there are 24 vaccines in clinical development, including two licensed vaccines.

PATHOGENS (2023)

暂无数据